Production of heparin-containing hydrogels for modulating cell responses.

Successful tissue regeneration requires that biomaterials have optimal bioactivity and mechanical properties. Heparin-containing hydrogels that can be crosslinked in situ were designed to contain tunable amounts of biological components (e.g. heparin, arginine-glycine-aspartate (RGD)) as well as to exhibit controlled mechanical properties (e.g. shear modulus). These gel parameters can also be tuned to provide controlled delivery of proteins, such as growth factors, for regulating cellular behavior. Maleimide-functionalized low-molecular-weight heparin (LWMH) was conjugated to a poly(ethylene glycol) (PEG) hydrogel. The elastic shear modulus, as assessed via oscillatory rheology experiments, could be tuned by the concentration of polymer in the hydrogel, and by the end group functionality of PEG. Hydrogels of two different moduli (2.8 and 0.4kPa) were used to study differences in the response of human aortic adventitial fibroblasts (AoAF) in two-dimensional cell culture experiments. These experiments indicated that the AoAFs show improved adhesion to materials with the higher modulus. Evaluation of cell responses to hydrogels with RGD linked to the hydrogels via conjugation to PEG or to LMWH indicated improved cellular responses to these materials when the bioactive ligands were chemically attached through linkage to the PEG rather than to the LMWH. These results highlight important design considerations in the tailoring of these materials for cardiovascular tissue engineering applications.

[1]  E. Furst,et al.  Growth factor mediated assembly of cell receptor-responsive hydrogels. , 2007, Journal of the American Chemical Society.

[2]  Horst Kessler,et al.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.

[3]  Eben Alsberg,et al.  Engineering growing tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[5]  B. Strauss,et al.  Adventitial fibroblasts: defining a role in vessel wall remodeling. , 2000, American journal of respiratory cell and molecular biology.

[6]  L. Glaser,et al.  A heparin-binding domain from N-CAM is involved in neural cell- substratum adhesion , 1986, The Journal of cell biology.

[7]  M. Karnovsky,et al.  Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells , 1997, Journal of cellular physiology.

[8]  M. Conte Molecular engineering of vein bypass grafts. , 2007, Journal of vascular surgery.

[9]  A. Hoffman,et al.  Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules. , 2007, Biomacromolecules.

[10]  K. Anseth,et al.  Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. , 2005, Acta biomaterialia.

[11]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[12]  Kristi L Kiick,et al.  Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. , 2005, Biomacromolecules.

[13]  S. Blystone,et al.  Heparin modulates integrin function in human platelets. , 2001, Journal of vascular surgery.

[14]  Antonio Giordano,et al.  Smart materials as scaffolds for tissue engineering , 2005, Journal of cellular physiology.

[15]  A. Chiavegato,et al.  Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.

[16]  A. Lumsden,et al.  Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. , 2004, Artificial organs.

[17]  Glenn D Prestwich,et al.  Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. , 2006, Tissue engineering.

[18]  Aaron D Baldwin,et al.  Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. Mikos,et al.  Integrin αvβ3 is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet‐derived growth factor , 2001 .

[20]  David J Mooney,et al.  Quantifying the relation between adhesion ligand–receptor bond formation and cell phenotype , 2006, Proceedings of the National Academy of Sciences.

[21]  R. Geary,et al.  Hyaluronan Enhances Contraction of Collagen by Smooth Muscle Cells and Adventitial Fibroblasts: Role of CD44 and Implications for Constrictive Remodeling , 2001, Circulation research.

[22]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[23]  K. Anseth,et al.  The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability , 2008, Journal of tissue engineering and regenerative medicine.

[24]  R. Linhardt,et al.  Immobilization of heparin: approaches and applications. , 2008, Current topics in medicinal chemistry.

[25]  E. Ruoslahti,et al.  Peptides in cell adhesion research. , 1994, Methods in enzymology.

[26]  Kenneth M. Yamada,et al.  Cell–matrix adhesion , 2007, Journal of cellular physiology.

[27]  Joyce Y. Wong,et al.  Balance of chemistry, topography, and mechanics at the cell–biomaterial interface: Issues and challenges for assessing the role of substrate mechanics on cell response , 2004 .

[28]  K. Fujiwara,et al.  Collagen modulates cell shape and cytoskeleton of embryonic corneal and fibroma fibroblasts: distribution of actin, alpha-actinin, and myosin. , 1982, Developmental biology.

[29]  Kenneth M. Yamada,et al.  Site-directed mutagenesis of the cell-binding domain of human fibronectin: Separable, synergistic sites mediate adhesive function , 1988, Cell.

[30]  A. Panitch,et al.  Viscoelastic Behavior of Environmentally Sensitive Biomimetic Polymer Matrices , 2006 .

[31]  E. Wijelath,et al.  Heparin Modulates Integrin-Mediated Cellular Adhesion: Specificity of Interactions with α and β Integrin Subunits , 2003 .

[32]  Kristi L Kiick,et al.  Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[33]  L G Griffith,et al.  Cell adhesion and motility depend on nanoscale RGD clustering. , 2000, Journal of cell science.

[34]  Laura E. Niklason,et al.  Mechanical Properties and Compositions of Tissue Engineered and Native Arteries , 2007, Annals of Biomedical Engineering.

[35]  G. Edelman,et al.  Binding properties of a cell adhesion molecule from neural tissue. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Donald E. Ingber,et al.  Tensegrity-based mechanosensing from macro to micro. , 2008, Progress in biophysics and molecular biology.

[37]  P. Cuevas,et al.  Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. , 1991, Circulation research.

[38]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[39]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.

[40]  S. Bryant,et al.  Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. , 1999, Circulation research.

[41]  B. Felding-Habermann,et al.  Selective Interaction of a Conformationally-constrained Arg-Gly- Asp (RGD) Motif with the Integrin Receptor αvβ3 Expressed on Human Tumor Cells , 1997 .

[42]  Gregory S. Schultz,et al.  TGF-β- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling , 2007 .

[43]  Shouren Ge,et al.  Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. , 2007, Biomaterials.

[44]  W. Schaper,et al.  Remodeling of the adventitia during coronary arteriogenesis. , 2003, American journal of physiology. Heart and circulatory physiology.

[45]  J. A. Hubbell,et al.  The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. , 2005, Biomaterials.

[46]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[47]  A. Panitch,et al.  Physical polymer matrices based on affinity interactions between peptides and polysaccharides. , 2003, Biomacromolecules.

[48]  A. Lander,et al.  Heparin inhibits the attachment and growth of Balb/c‐3T3 fibroblasts on collagen substrata , 1992, Journal of cellular physiology.

[49]  K. Stenmark,et al.  Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. , 2006, The American journal of pathology.

[50]  Glenn D Prestwich,et al.  Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. , 2004, Journal of biomedical materials research. Part A.

[51]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[52]  K. Stenmark,et al.  Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. , 2004, American journal of physiology. Cell physiology.

[53]  Douglas W DeSimone,et al.  Cell adhesion receptors in mechanotransduction. , 2008, Current opinion in cell biology.